Drugs & TargetsFree FDA grants fourth breakthrough designation to Imbruvica July 01, 2016Vol.42 No.26
FreeIn Brief American Cancer Society plans to double research budget in five years July 01, 2016Vol.42 No.26
FreeIn Brief Firas Eladoumikdachi named program director at Rutgers Cancer Institute of New Jersey at Hamilton July 01, 2016Vol.42 No.26
FreeIn Brief Stephen Burley named leader of cancer pharmacology research at Rutgers Cancer Institute of New Jersey July 01, 2016Vol.42 No.26
Conversation with The Cancer LetterFree Pazdur Named Acting Director of FDA’s New Cancer Center July 01, 2016Vol.42 No.26By Matthew Bin Han Ong
FreeNews Analysis Biden’s Moonshot Goals are Flexible Enough to be Realistic July 01, 2016Vol.42 No.26By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Hirsch: I Dropped Out of Stanford to Start Syapse June 24, 2016Vol.42 No.25By Matthew Bin Han Ong
